Research Groups and R&D Platforms: Biomarker

Picture of Urpo Lamminmäki

Research Group:
Recombinant antibodies and other bioaffinity molecules

Urpo Lamminmäki

Department of Life Technologies,
University of Turku

Urpo Lamminmäki

Antibodies, Assay development, Basic research, Biomarker, Biotechnology, Cancer, Combinatorial chemistry, Diagnostics, Drug target, Fluorescence spectroscopy, Hit to lead, In Vitro Diagnostics, Infection, Lead optimization, Metabolic diseases, Molecular Biology, Molecular modelling, Nanoparticles, Next-generation sequencing, Ovarian cancer, Point of care, Prostate cancer, Screening, Synthetic Biology, Target discovery